Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Pseudomyxoma peritonei (PMP) treatment is hindered by poor drug penetration through dense mucinous tumors.
• Poly (lactic-co-glycolic acid)-b-polyethylene glycol nanoparticles (PLGA-PEG-NPs) were modified with a second PEG layer (PLGA-TPEG-NPs-20) to reduce protein binding and enhance mucin diffusion.

Purpose of the Study:

• To develop and evaluate a novel nanoparticle formulation for improved drug delivery in PMP.
• To assess the mucin-penetrating capabilities of PLGA-TPEG-NPs-20 compared to conventional PLGA-PEG-NPs.

Main Methods:

• Nanoprecipitation was used to fabricate PLGA-PEG-NPs and PLGA-TPEG-NPs-20.
• Nanoparticle diffusion was assessed using trans-well systems with cultured cells and PMP tissue.
• Ex vivo and in vivo models (rat small intestine, murine subcutaneous tumors) were employed to evaluate NP diffusion and distribution.

Main Results:

• PLGA-TPEG-NPs-20 exhibited significantly enhanced diffusion (100% penetration) compared to PLGA-PEG-NPs (40% penetration) over 8 hours.
• Increased NP diffusion was confirmed in ex vivo rat small intestine models.
• In vivo studies showed homogenous fluorescence signal throughout subcutaneous tumors treated with PLGA-TPEG-NPs-20, indicating superior tumor penetration.

Conclusions:

• PLGA-TPEG-NPs-20 demonstrate superior mucin penetration capabilities.
• This modified nanoparticle system holds promise as an effective drug delivery platform for pseudomyxoma peritonei.